These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 21679214

  • 1. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J, OBIS Study Investigators.
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [Abstract] [Full Text] [Related]

  • 2. Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.
    Chmielewska-Wilkoń D, Reggiardo G, Egan CG.
    World J Gastroenterol; 2014 Sep 14; 20(34):12283-91. PubMed ID: 25232263
    [Abstract] [Full Text] [Related]

  • 3. Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy.
    Baldi F, Longanesi A, Blasi A, Monello S, Cestari R, Missale G, Corazziari E, Badiali G, Pescatori M, Anastasio G.
    Ital J Gastroenterol; 1991 Nov 14; 23(8 Suppl 1):60-3. PubMed ID: 1756285
    [Abstract] [Full Text] [Related]

  • 4. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 5. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
    Tack JF, Miner PB, Fischer L, Harris MS.
    Aliment Pharmacol Ther; 2011 Oct 15; 34(8):868-77. PubMed ID: 21883322
    [Abstract] [Full Text] [Related]

  • 6. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.
    Pace F, Maurano A, Ciacci C, Savarino V, Attili A, Iaquinto G, Magni E, Porro GB.
    Eur Rev Med Pharmacol Sci; 2010 Mar 15; 14(3):155-62. PubMed ID: 20391952
    [Abstract] [Full Text] [Related]

  • 7. Irritable bowel syndrome: focus on otilonium bromide.
    Boeckxstaens G, Clavé P, Corazziari ES, Tack J.
    Expert Rev Gastroenterol Hepatol; 2014 Feb 15; 8(2):131-7. PubMed ID: 24417261
    [Abstract] [Full Text] [Related]

  • 8. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
    Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain MC.
    Aliment Pharmacol Ther; 2010 Mar 15; 31(6):615-24. PubMed ID: 20003095
    [Abstract] [Full Text] [Related]

  • 9. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
    Quigley EM, Tack J, Chey WD, Rao SS, Fortea J, Falques M, Diaz C, Shiff SJ, Currie MG, Johnston JM.
    Aliment Pharmacol Ther; 2013 Jan 15; 37(1):49-61. PubMed ID: 23116208
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the action of otilonium bromide and pinaverium bromide: study conducted under clinical control.
    Defrance P, Casini A.
    Ital J Gastroenterol; 1991 Nov 15; 23(8 Suppl 1):64-6. PubMed ID: 1756286
    [Abstract] [Full Text] [Related]

  • 11. Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.
    Zakko S, Barton G, Weber E, Dunger-Baldauf C, Rühl A.
    Aliment Pharmacol Ther; 2011 Jun 15; 33(12):1311-21. PubMed ID: 21507028
    [Abstract] [Full Text] [Related]

  • 12. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA.
    Am J Gastroenterol; 2011 Oct 15; 106(10):1813-20. PubMed ID: 21647206
    [Abstract] [Full Text] [Related]

  • 13. [Otilonium bromide-diazepam in the treatment of the irritable colon. A controlled study versus otilonium bromide].
    Mollica G, Manno G.
    Clin Ter; 1992 Aug 15; 141(8):129-34. PubMed ID: 1395455
    [Abstract] [Full Text] [Related]

  • 14. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
    Mangel AW, Bornstein JD, Hamm LR, Buda J, Wang J, Irish W, Urso D.
    Aliment Pharmacol Ther; 2008 Jul 15; 28(2):239-49. PubMed ID: 18466359
    [Abstract] [Full Text] [Related]

  • 15. Is otilonium bromide globally effective in irritable bowel syndrome?
    Desborough MJ, Ford AC.
    Aliment Pharmacol Ther; 2011 Oct 15; 34(8):1034-5; author reply 1035-6. PubMed ID: 21933208
    [No Abstract] [Full Text] [Related]

  • 16. Aleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndrome.
    Villagrasa M, Boix J, Humbert P, Quer JC.
    Ital J Gastroenterol; 1991 Nov 15; 23(8 Suppl 1):67-70. PubMed ID: 1661630
    [Abstract] [Full Text] [Related]

  • 17. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.
    Tuteja AK, Fang JC, Al-Suqi M, Stoddard GJ, Hale DC.
    Scand J Gastroenterol; 2012 Oct 15; 47(10):1159-64. PubMed ID: 22783919
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
    Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR.
    Neurogastroenterol Motil; 2005 Oct 15; 17(5):687-96. PubMed ID: 16185307
    [Abstract] [Full Text] [Related]

  • 19. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ.
    Gastroenterology; 2006 Oct 15; 131(4):1003-10. PubMed ID: 17030170
    [Abstract] [Full Text] [Related]

  • 20. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
    Guandalini S, Magazzù G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, Setty M.
    J Pediatr Gastroenterol Nutr; 2010 Jul 15; 51(1):24-30. PubMed ID: 20453678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.